HABIT efficacy and sustainability trial, a multi-center randomized controlled trial to improve hydroxyurea adherence in youth with sickle cell disease: a study protocol
Abstract Background Hydroxyurea (HU) is recommended as standard practice for youth with sickle cell disease (SCD). Yet, despite its efficacy, HU adherence in adolescents and young adults is often poor. Poor medication adherence increases disease burden, healthcare cost and widens health disparities....
Saved in:
Main Authors: | Arlene Smaldone (Author), Deepa Manwani (Author), Banu Aygun (Author), Kim Smith-Whitley (Author), Haomiao Jia (Author), Jean-Marie Bruzzese (Author), Sally Findley (Author), Joshua Massei (Author), Nancy S. Green (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015) -
Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
by: Daniela Di Grazia, et al.
Published: (2024) -
Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022) -
A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study
by: Creary, Susan, et al.
Published: (2019) -
Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient
by: Mayur S. Dudhe, et al.
Published: (2023)